pharmaphorum27m
Revolutionising clinical trials: The promise of AI-driven subgroup analysis
With only 12% 1 of therapies surviving the gauntlet of Phase III trials to receive FDA approval, and the cost to bring a drug ...
Buy Rating Affirmed for Plus Therapeutics Amidst ReSPECT-GBM Trial Progress and Overlooked Market Potential
In a report released today, Justin Walsh from JonesTrading reiterated a Buy rating on Plus Therapeutics (PSTV – Research Report), with a ...
Hosted on MSN19h
Newly discovered mechanism identified in the initial stages of Alzheimer's disease
The failure of clinical trials using gamma-secretase inhibitors ... the researchers will carry out more research on cellular homeostasis in the early phases of AD and will collaborate with colleagues ...
News Medical21h
How can trial customization progress CAR T-cell therapy?
Car-T cell therapy has changed the face of many cancer treatments, but the level of customization it requires still comes ...
Expert Systems Celebrates Milestone in Clinical Development of Ratutrelvir, Potential Best-in-Class COVID Candidate
Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, celebrates a key milestone in the development of ratutrelvir, a SARS-CoV-2 Main protease (Mpro) ...
Business Insider5h
Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program
He has designed and led all phases of oncology clinical trials, including large Phase III registration studies involving over 2,000 patients. Throughout his career, Dr. Iglesias has made significant ...
Allarity Therapeutics, Inc.: Allarity Therapeutics Strengthens Leadership with Key Appointments to Accelerate Stenoparib PARP Inhibitor Program
Former Eli Lilly Research Fellow Jeremy R. Graff, Ph.D., appointed as President and Chief Development Officer to lead the Company's clinical development programsEli Lilly and Celgene veteran Jose Igle ...
TMO Stock Likely to Gain From New International CorEvitas AD Registry
The latest CorEvitas registry – the company’s 11th independent registry – will allow the prospective evaluation of adolescent AD patients to better understand the disease and the treatment pathway. It ...
Safer Psychedelic Drugs May Be Coming
Classic psychedelics, some advocates argue, come with too much baggage. But these altered, “next generation” medications may ...
TMCnet23h
Immix Biopharma Advances CAR-T NXC-201 to Expansion Cohort Dose Level in U.S. AL Amyloidosis Trial NEXICART-2
NXC-201 is the only CAR-T therapy currently in development in AL Amyloidosis, mentioned in a review article entitled “Systemic Light Chain Amyloidosis” published in June, 2024 New England Journal of ...
Here’s what fear does to your brain and your body
Your brain can’t always tell the difference between a jump scare and a real threat. But what’s thrilling for some people can ...
Hosted on MSN1h
The 5 types of friendship we all need for optimal happiness
Research shows that people need between three to five close ... energy to sustain more than five close friendships at any given time,” Lauren Napolitano, a clinical psychologist practicing in ...